Additionally, CD52 overexpression resulted in significant increase in ATP, glucose and lactate levels in NSCLC cells (p < 0.01), which were partially restored after 2-DG treatment (Fig. 5B-5D). The gene discussed is CD52; the disease is non-small cell lung carcinoma.